GIM
Greylin Investment Management Portfolio holdings
AUM
$598M
This Quarter Return
+1.87%
1 Year Return
+18.59%
3 Year Return
+52.1%
5 Year Return
+133.55%
10 Year Return
+215.01%
AUM
$445M
AUM Growth
+$445M
(+0.03%)
Cap. Flow
-$7.55M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
80
New
3
Increased
15
Reduced
42
Closed
11
Top Buys
| 1 |
Occidental Petroleum
OXY
|
$12.1M |
| 2 |
Kraft Heinz
KHC
|
$5.49M |
| 3 |
Schlumberger
SLB
|
$3.96M |
| 4 |
Skyworks Solutions
SWKS
|
$1.82M |
| 5 |
United Therapeutics
UTHR
|
$1.65M |
Top Sells
| 1 |
AB InBev
BUD
|
$4.02M |
| 2 |
USG
Usg
USG
|
$3.58M |
| 3 |
BP
BP
|
$3.35M |
| 4 |
Tapestry
TPR
|
$2.82M |
| 5 |
NXP Semiconductors
NXPI
|
$2.34M |
Sector Composition
| 1 | Financials | 37.24% |
| 2 | Energy | 23.16% |
| 3 | Technology | 17.81% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Staples | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Skyworks Solutions
SWKS
$10.9B
| $2.62M | 0.59% |
33,887
+23,505
| +226% | +$1.82M |
|
27
Cisco
CSCO
$268B
| $2.57M | 0.58% |
46,864
-2,000
| -4% | -$109K |
|
28
PepsiCo
PEP
$203B
| $2.43M | 0.55% |
18,520
-4,940
| -21% | -$648K |
|
29
Lowe's Companies
LOW
$146B
| $2.23M | 0.5% |
22,070
-235
| -1% | -$23.7K |
|
30
Eli Lilly
LLY
$661B
| $2.21M | 0.5% |
19,910
-2,760
| -12% | -$306K |
|
31
Pfizer
PFE
$141B
| $2.04M | 0.46% |
47,085
-3,225
| -6% | -$140K |
|
|
CHK
32
DELISTED
Chesapeake Energy Corporation
CHK
| $1.9M | 0.43% |
972,230
+166,290
| +21% | +$324K |
|
33
FedEx
FDX
$53.2B
| $1.76M | 0.4% |
10,717
+2,194
| +26% | +$360K |
|
34
WPP
WPP
$5.73B
| $1.41M | 0.32% |
22,420
+7,875
| +54% | +$495K |
|
35
Synchrony
SYF
$28.1B
| $1.35M | 0.3% |
38,975
-4,800
| -11% | -$166K |
|
36
Wabash National
WNC
$451M
| $1.21M | 0.27% |
74,470
-15,040
| -17% | -$245K |
|
37
Chevron
CVX
$318B
| $1.12M | 0.25% |
8,995
-765
| -8% | -$95.2K |
|
38
Apple
AAPL
$3.54T
| $1.1M | 0.25% |
5,535
-200
| -3% | -$39.6K |
|
39
M&T Bank
MTB
$31B
| $1.06M | 0.24% |
6,250
| – | – |
|
|
40
AB InBev
BUD
$116B
| $1.04M | 0.23% |
11,750
-45,470
| -79% | -$4.02M |
|
41
Honeywell
HON
$136B
| $1.03M | 0.23% |
5,925
| – | – |
|
42
Gilead Sciences
GILD
$140B
| $1.02M | 0.23% |
15,047
+3,600
| +31% | +$243K |
|
43
JPMorgan Chase
JPM
$824B
| $959K | 0.22% |
8,575
-115
| -1% | -$12.9K |
|
44
Procter & Gamble
PG
$370B
| $948K | 0.21% |
8,643
| – | – |
|
45
J.M. Smucker
SJM
$12B
| $919K | 0.21% |
7,980
| – | – |
|
46
Helmerich & Payne
HP
$2B
| $912K | 0.2% |
18,015
-32,665
| -64% | -$1.65M |
|
47
Sprott Physical Gold and Silver Trust
CEF
$6.46B
| $743K | 0.17% |
56,150
-26,250
| -32% | -$347K |
|
48
Phillips 66
PSX
$52.8B
| $696K | 0.16% |
7,445
-13,225
| -64% | -$1.24M |
|
49
Abbott
ABT
$230B
| $691K | 0.16% |
8,215
-2,750
| -25% | -$231K |
|
50
Zimmer Biomet
ZBH
$20.8B
| $600K | 0.13% |
5,100
-25
| -0.5% | -$2.97K |
|